Madrigal Pharmaceuticals Inc (MDGL)
312.00
+1.13
(+0.36%)
USD |
NASDAQ |
Dec 24, 16:00
Madrigal Pharmaceuticals Cash from Investing (Quarterly): -202.39M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics Inc | -44.04M |
| 89bio Inc | -8.639M |
| ADMA Biologics Inc | -1.098M |
| Matinas BioPharma Holdings Inc | 9.646M |
| Viking Therapeutics Inc | 25.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -66.98M |
| Cash from Financing (Quarterly) | 7.462M |
| Free Cash Flow | -438.32M |
| Free Cash Flow Per Share (Quarterly) | -3.116 |
| Free Cash Flow to Equity (Quarterly) | -68.24M |
| Free Cash Flow Yield | -6.78% |